GLS1 is a Protective Factor Rather than a Molecular Target in ARID1A-Mutated Ovarian Clear Cell Carcinoma
V. Clemente, A. Nelson, B. Erickson, R. Baker, N. Rubin, M. Khalifa, A. Hoshino, M. Shetty, E. Lou, M. Bazzaro
The paper investigates GLS1 expression in ARID1A-mutated ovarian clear cell carcinoma and finds it is not correlated with ARID1A loss and is associated with better clinical outcomes.
bioRxiv · Sep 3, 2021 · PreprintCancer Biology